USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cathay (jinxiang). Biomaterial Co., Ltd.

USPTO PatentsView assignee record - 6 granted patents across 9 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

15.5

Avg claims per patent

5-year filing velocity

The verdict

Cathay holds 6 US patents across 9 technology areas, rank #39,518 of 50,000 tracked assignees.

#39,518
of 50,000 US assignees by volume: Top 20%
by Innovation Score (46.6/100): 15.5
avg claims per patent

Portfolio overview

Cathay (jinxiang). Biomaterial Co., Ltd. has been granted 6 US utility patents between 2021 and 2025, placing Cathay (jinxiang). Biomaterial Co., Ltd. at rank #39,518 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.5 claims per patent with primary concentration in C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS). As a Foreign Corporation, Cathay (jinxiang). Biomaterial Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Cathay sits between Cascade Technologies Holdings Limited (6 patents, rank #39,514) and Cefaly Technology SPRL (6 patents, rank #39,522) - the closest US assignees by grant volume. The composite Innovation Score of 46.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cathay (jinxiang). Biomaterial Co., Ltd.'s 15.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cathay (jinxiang). Biomaterial Co., Ltd. against peers pursuing similar technology classes.

Cascade Holdings

6
Casemed Engineeri…

6
Cassava Sciences

6
Caterpiller

6
Cathedral Energy…

6
Catis Pacific Mfg

6
Cbros

6
Cefaly Technology…

6
Cathay (Jinxiang)… ◀

6

What this shows Cathay holds 6 patents at rank #39,518, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cathay

By rank, the assignees closest to #39,518 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Cathay's primary technology class.

Cathay's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Cathay (jinxiang). Biomaterial Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	16.7%
2022	1	16.7%
2023	1	16.7%
2024	2	33.3%
2025	1	16.7%

Which technologies does Cathay (jinxiang). Biomaterial Co., Ltd. patent most?

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 5

B01D - SEPARATION 4

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 2

D06P - DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM 1

D01F - CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS 1

D02G - CRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS 1

D10B - INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES 1

D01D - MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS 1

Top 9 of 9 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Where it ranks

Overall rank by patents

#39,518

Across all tracked assignees

Innovation Score

46.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cathay (jinxiang). Biomaterial Co., Ltd. hold?

Cathay (jinxiang). Biomaterial Co., Ltd. holds 6 US granted patents filed between 2021 and 2025, spanning 9 technology areas.

What is Cathay (jinxiang). Biomaterial Co., Ltd.'s Innovation Score?

Cathay (jinxiang). Biomaterial Co., Ltd. has an Innovation Score of 46.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cathay (jinxiang). Biomaterial Co., Ltd. focus on?

Cathay (jinxiang). Biomaterial Co., Ltd.'s top technology area is C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS) with 5 patents. The company has filed patents in 9 CPC subclasses total.

Is Cathay (jinxiang). Biomaterial Co., Ltd.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Cathay (jinxiang). Biomaterial Co., Ltd..

What does claim depth mean for Cathay (jinxiang). Biomaterial Co., Ltd.'s patents?

Cathay (jinxiang). Biomaterial Co., Ltd.'s patents average 15.5 claims each. This falls within the standard range, providing solid legal coverage.

How is the Cathay (jinxiang). Biomaterial Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cathay's 6 grants land it in the top 20% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Cathay ranks #39,518 of 50,000. Top 50 holders
Most of this portfolio concentrates in C07C - see who else leads that technology area. C07C leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.